{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:44:09Z","timestamp":1770813849765,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,10]]},"DOI":"10.7759\/cureus.103346","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T12:31:51Z","timestamp":1770726711000},"source":"Crossref","is-referenced-by-count":0,"title":["Trends in Mortality Rates From Hemophagocytic Lymphohistiocytosis in the United States From 2010 to 2023"],"prefix":"10.7759","author":[{"given":"James","family":"Di Palma-Grisi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan","family":"Locke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffen","family":"Kulp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suraj","family":"Pothineni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harsh","family":"Parmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.735796","article-title":"High mortality of HLH in ICU regardless etiology or treatment","volume":"8","author":"Bichon A","year":"2021","unstructured":"Bichon A, Bourenne J, Allardet-Servent J, et al.. High mortality of HLH in ICU regardless etiology or treatment. Front Med (Lausanne). 2021, 8:735796. 10.3389\/fmed.2021.735796","journal-title":"Front Med (Lausanne)"},{"key":"ref2","unstructured":"Provisional mortality statistics by multiple cause of death and by single race, for 2018 through present. (2024). Accessed. July 22, 2025: https:\/\/wonder.cdc.gov\/wonder\/help\/mcd-provisional.html."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2020.101515","article-title":"Hemophagocytic lymphohistiocytosis: an update on pathogenesis, diagnosis, and therapy","volume":"34","author":"Griffin G","year":"2020","unstructured":"Griffin G, Shenoi S, Hughes GC. Hemophagocytic lymphohistiocytosis: an update on pathogenesis, diagnosis, and therapy. Best Pract Res Clin Rheumatol. 2020, 34:101515. 10.1016\/j.berh.2020.101515","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.95627","article-title":"Hemophagocytic lymphohistiocytosis in HIV\/AIDS: who fired the first shot, the virus or its companions?","volume":"17","author":"Parsi S","year":"2025","unstructured":"Parsi S, Ponnam HC, Sakamuri L, Kashyap R. Hemophagocytic lymphohistiocytosis in HIV\/AIDS: who fired the first shot, the virus or its companions?. Cureus. 2025, 17:e95627. 10.7759\/cureus.95627","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017005561","article-title":"Proliferation through activation: hemophagocytic lymphohistiocytosis in hematologic malignancy","volume":"1","author":"Vick EJ","year":"2017","unstructured":"Vick EJ, Patel K, Prouet P, Martin MG. Proliferation through activation: hemophagocytic lymphohistiocytosis in hematologic malignancy. Blood Adv. 2017, 1:779-91. 10.1182\/bloodadvances.2017005561","journal-title":"Blood Adv"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2314005","article-title":"Hemophagocytic lymphohistiocytosis","volume":"392","author":"Henter JI","year":"2025","unstructured":"Henter JI. Hemophagocytic lymphohistiocytosis. N Engl J Med. 2025, 392:584-98. 10.1056\/NEJMra2314005","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18617","article-title":"Epidemiology of haemophagocytic lymphohistiocytosis at the population level in Germany","volume":"201","author":"Kuron D","year":"2023","unstructured":"Kuron D, Voran JC, von Samson-Himmelstjerna FA, Baldus C, Kunzendorf U, Schulte K, Kolbrink B. Epidemiology of haemophagocytic lymphohistiocytosis at the population level in Germany. Br J Haematol. 2023, 201:285-9. 10.1111\/bjh.18617","journal-title":"Br J Haematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez379","article-title":"Haemophagocytic lymphohisticytosis-an underrecognized hyperinflammatory syndrome","volume":"58","author":"Hutchinson M","year":"2019","unstructured":"Hutchinson M, Tattersall RS, Manson JJ. Haemophagocytic lymphohisticytosis-an underrecognized hyperinflammatory syndrome. Rheumatology (Oxford). 2019, 58:vi23-30. 10.1093\/rheumatology\/kez379","journal-title":"Rheumatology (Oxford)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12041696","article-title":"Mortality and associated causes in hemophagocytic lymphohistiocytosis: a multiple-cause-of-death analysis in France","volume":"12","author":"La Marle S","year":"2023","unstructured":"La Marle S, Richard-Colmant G, Fauvernier M, Ghesqui\u00e8res H, Hot A, S\u00e8ve P, Jamilloux Y. Mortality and associated causes in hemophagocytic lymphohistiocytosis: a multiple-cause-of-death analysis in France. J Clin Med. 2023, 12:14-6. 10.3390\/jcm12041696","journal-title":"J Clin Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02135-8","article-title":"Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis","volume":"38","author":"Knauft J","year":"2024","unstructured":"Knauft J, Schenk T, Ernst T, Schnetzke U, Hochhaus A, La Ros\u00e9e P, Birndt S. Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis. Leukemia. 2024, 38:235-49. 10.1038\/s41375-024-02135-8","journal-title":"Leukemia"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1532\/IJH97.07012","article-title":"Nationwide survey of hemophagocytic lymphohistiocytosis in Japan","volume":"86","author":"Ishii E","year":"2007","unstructured":"Ishii E, Ohga S, Imashuku S, et al.. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol. 2007, 86:58-65. 10.1532\/IJH97.07012","journal-title":"Int J Hematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000001048","article-title":"Hemophagocytic lymphohistiocytosis: potentially underdiagnosed in intensive care units","volume":"50","author":"Lachmann G","year":"2018","unstructured":"Lachmann G, Spies C, Schenk T, Brunkhorst FM, Balzer F, La Ros\u00e9e P. Hemophagocytic lymphohistiocytosis: potentially underdiagnosed in intensive care units. Shock. 2018, 50:149-55. 10.1097\/SHK.0000000000001048","journal-title":"Shock"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023020715","article-title":"Malignancy-associated hemophagocytic lymphohistiocytosis in Sweden: incidence, clinical characteristics, and survival","volume":"143","author":"L\u00f6fstedt A","year":"2024","unstructured":"L\u00f6fstedt A, J\u00e4dersten M, Meeths M, Henter JI. Malignancy-associated hemophagocytic lymphohistiocytosis in Sweden: incidence, clinical characteristics, and survival. Blood. 2024, 143:233-42. 10.1182\/blood.2023020715","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2010.551153","article-title":"Malignancy-associated hemophagocytic lymphohistiocytosis in adults: a retrospective population-based analysis from a single center","volume":"52","author":"Machaczka M","year":"2011","unstructured":"Machaczka M, Vaktn\u00e4s J, Klimkowska M, H\u00e4gglund H. Malignancy-associated hemophagocytic lymphohistiocytosis in adults: a retrospective population-based analysis from a single center. Leuk Lymphoma. 2011, 52:613-9. 10.3109\/10428194.2010.551153","journal-title":"Leuk Lymphoma"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17768","article-title":"A validation study of the identification of haemophagocytic lymphohistiocytosis in England using population-based health data","volume":"194","author":"Bishton MJ","year":"2021","unstructured":"Bishton MJ, Stilwell P, Card TR, et al.. A validation study of the identification of haemophagocytic lymphohistiocytosis in England using population-based health data. Br J Haematol. 2021, 194:1039-44. 10.1111\/bjh.17768","journal-title":"Br J Haematol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(25)00292-9","article-title":"Trends in mortality due to haemophagocytic lymphohistiocytosis across 29 European countries from 2011 to 2021: a retrospective, international, population-based study","volume":"8","author":"Gumber L","year":"2026","unstructured":"Gumber L, Omidvar R, Gonnelli F, et al.. Trends in mortality due to haemophagocytic lymphohistiocytosis across 29 European countries from 2011 to 2021: a retrospective, international, population-based study. Lancet Rheumatol. 2026, 8:e108-15. 10.1016\/S2665-9913(25)00292-9","journal-title":"Lancet Rheumatol"},{"key":"ref17","unstructured":"Centers for Disease Control and Prevention, National Center for Health Statistics. National Vital Statistics System, Provisional Mortality on CDC WONDER Online Database. Data are from the final Multiple Cause of Death Files, 2018-2023, and from provisional data for years 2024 and later, as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program. (2024). Accessed. July 22, 2025: http:\/\/wonder.cdc.gov\/mcd-icd10-provisional.html."},{"key":"ref18","unstructured":"World Health Organization. International Statistical Classification of Diseases and Related Health Problems. (2019). Accessed: July 22, 2025: https:\/\/icd.who.int\/."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024025077","article-title":"Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisited","volume":"144","author":"Henter JI","year":"2024","unstructured":"Henter JI, Sieni E, Eriksson J, et al.. Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisited. Blood. 2024, 144:2308-18. 10.1182\/blood.2024025077","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter JI","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, et al.. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007, 48:124-31. 10.1002\/pbc.21039","journal-title":"Pediatr Blood Cancer"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet L","year":"2014","unstructured":"Fardet L, Galicier L, Lambotte O, et al.. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014, 66:2613-20. 10.1002\/art.38690","journal-title":"Arthritis Rheumatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021012764","article-title":"An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis","volume":"139","author":"Zoref-Lorenz A","year":"2022","unstructured":"Zoref-Lorenz A, Murakami J, Hofstetter L, et al.. An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis. Blood. 2022, 139:1098-110. 10.1182\/blood.2021012764","journal-title":"Blood"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.e200","article-title":"Serum soluble CD25 and ferritin in distinguishing patients with uncomplicated hematologic malignancies from patients with hematologic malignancies complicated by hemophagocytic lymphohistiocytosis","volume":"38","author":"Lorenz AZ","year":"2020","unstructured":"Lorenz AZ, Hofstetter L, Murakami J, et al.. Serum soluble CD25 and ferritin in distinguishing patients with uncomplicated hematologic malignancies from patients with hematologic malignancies complicated by hemophagocytic lymphohistiocytosis. J Clin Oncol. 2020, 38:e20072. 10.1200\/JCO.2020.38.15_suppl.e200","journal-title":"J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/458438-trends-in-mortality-rates-from-hemophagocytic-lymphohistiocytosis-in-the-united-states-from-2010-to-2023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T12:31:54Z","timestamp":1770726714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/458438-trends-in-mortality-rates-from-hemophagocytic-lymphohistiocytosis-in-the-united-states-from-2010-to-2023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.103346","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,10]]}}}